Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05319444 · ClinicalTrials.gov registry record · NA
Cleansing Device for the Treatment of Scalp and Hair Conditions
A NA study, sponsored by University of Minnesota.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05319444: Clinical Trial NA study, sponsored by University of Minnesota.
NCT05319444 is a NA study that was terminated before completion, run by University of Minnesota. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05319444, a NA study, was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate an improvement of scalp health after the use of an investigational off-label WaterPik and brush device aimed to massage and cleanse the scalp.
Primary Outcome
The presence of dandruff flakes adhereing to the scalp in 8 defined areas is rated on a scale of 0-10 per area, where 0 indicates no flakes and 10 indicates heavy flaking. This is combined for total scores ranging from 0-80.
Interventions
- DEVICE Off-brand Waterpik®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2022-05-27 |
| Est. Completion | 2023-05-12 |
| Phase | NA |
Why NCT05319444 stopped before completion
NCT05319444 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Off-brand Waterpik® is the first listed.
NCT05319444 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05319444 about?
NCT05319444 is a clinical study titled "Cleansing Device for the Treatment of Scalp and Hair Conditions". The objective of this study is to evaluate an improvement of scalp health after the use of an investigational off-label WaterPik and brush device aimed to massage and cleanse the scalp.
What is the current status of trial NCT05319444?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2022-05-27. Estimated completion is 2023-05-12.
What interventions are being tested in trial NCT05319444?
The interventions under investigation include: Off-brand Waterpik® (DEVICE).
Who is sponsoring clinical trial NCT05319444?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05319444's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI